These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1859455

  • 1. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD, Gupta V, Awasthi YC.
    Biochem Pharmacol; 1991 Jul 05; 42(2):439-41. PubMed ID: 1859455
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
    Ripple M, Mulcahy RT, Wilding G.
    J Urol; 1993 Jul 05; 150(1):209-14. PubMed ID: 8510259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.
    Somfai-Relle S, Suzukake K, Vistica BP, Vistica DT.
    Biochem Pharmacol; 1984 Feb 01; 33(3):485-90. PubMed ID: 6704165
    [No Abstract] [Full Text] [Related]

  • 9. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
    Barranco SC, Townsend CM, Weintraub B, Beasley EG, MacLean KK, Shaeffer J, Liu NH, Schellenberg K.
    Cancer Res; 1990 Jun 15; 50(12):3614-8. PubMed ID: 2340510
    [Abstract] [Full Text] [Related]

  • 10. Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
    Jevtović-Todorović V, Guenthner TM.
    Biochem Pharmacol; 1992 Oct 06; 44(7):1383-93. PubMed ID: 1417960
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF.
    Cancer Res; 1984 Nov 06; 44(11):5427-31. PubMed ID: 6488194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.
    Canada A, Herman L, Kidd K, Robertson C, Trump D.
    Cancer Chemother Pharmacol; 1993 Nov 06; 32(1):73-7. PubMed ID: 8462127
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
    Friedman HS, Colvin OM, Griffith OW, Lippitz B, Elion GB, Schold SC, Hilton J, Bigner DD.
    J Natl Cancer Inst; 1989 Apr 05; 81(7):524-7. PubMed ID: 2921776
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.